Maspin is expressed predominantly in normal mammary epithelial cells but significantly reduced or absent in most of breast carcinomas, prostate cancer (CaP), gastric malignant tissue, and melanoma cancers, yet is overexpressed in pancreatic, gallbladder, colorectal, and thyroid cancers. This evidence concerns the gene SERPINB5 and prostate carcinoma.